B7-2/CD86 Antibody (BU63) [Allophycocyanin] Summary
ARH-77 (B-lymphoblastoid cell line)
DC Maturation Marker
Recognizes a protein of 70kDa, which is identified as CD86 (HLDA V; WS Code BP BP072. HLDA V; WS Code A A109. HLDA VI; WS Code BP 95. HLDA VI; WS Code B CD86.9). CD86 is a type I transmembrane glycoprotein and a member of the immunoglobulin superfamily of cell surface receptors. It is expressed at high levels on resting peripheral monocytes and dendritic cells and at very low density on resting B and T lymphocytes. CD86 expression is rapidly upregulated by B cell specific stimuli with peak expression at 18 to 42 hours after stimulation. CD86, along with CD80/B71, is an important accessory molecule in T cell co-stimulation via its interaction with CD28 and CD152/CTLA4. Since CD86 has rapid kinetics of induction, it is believed to be the major CD28 ligand expressed early in the immune response. It is also found on malignant Hodgkin and Reed Sternberg (HRS) cells in Hodgkin's disease.
Protein G purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Packaging, Storage & Formulations
Store at 4C in the dark.
0.05% Sodium Azide
Protein G purified
This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
Alternate Names for B7-2/CD86 Antibody (BU63) [Allophycocyanin]
- Activation B7-2 antigen
- B7-2 antigen
- B-lymphocyte activation antigen B7-2
- CD28 antigen ligand 2
- CD28LG2B7-2 antigen)
- CD86 antigen
- CD86 molecule
- CTLA-4 counter-receptor B7.2
- T-lymphocyte activation antigen CD86
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed
for 1 year from date of receipt.
Customers Who Viewed This Item Also Viewed...
Applications: Flow, IHC, CyTOF-ready, ELISA(Cap), ELISA(Det), Neut, ELISA(Sta)
Applications: WB, Flow, CyTOF-ready, ICC
Applications: WB, ELISA, Flow, IHC, CyTOF-ready
Species: Hu, Mu
Applications: WB, Flow, ICC/IF, IHC, IHC-P, IP, Flow-IC
Species: Hu, Mu, Rt, Po, Bv
Applications: WB, ICC/IF
Applications: Flow, Func, ICC/IF, IHC, IHC-Fr, IHC-P
Applications: WB, AgAct
Applications: Flow, CyTOF-ready, ICC
Species: Hu, Mu, Rt, Ca, Rb
Applications: WB, Simple Western, ICC/IF, IHC, IHC-P
Species: Hu, Mu, Rt
Applications: WB, ICC/IF, IHC, IHC-P
Applications: WB, IP
Species: Hu, Mu, Rt
Publications for B7-2/CD86 Antibody (NBP2-34569APC) (0)
There are no publications for B7-2/CD86 Antibody (NBP2-34569APC).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for B7-2/CD86 Antibody (NBP2-34569APC) (0)
There are no reviews for B7-2/CD86 Antibody (NBP2-34569APC).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
- 1st to review with an image -- $50/€35/£30/$50 CAD/¥300 Yuan/¥5000 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
FAQs for B7-2/CD86 Antibody (NBP2-34569APC) (0)
Additional B7-2/CD86 Products
Bioinformatics Tool for B7-2/CD86 Antibody (NBP2-34569APC)
Discover related pathways, diseases and genes to B7-2/CD86 Antibody (NBP2-34569APC). Need help?
Read the Bioinformatics Tool Guide
for instructions on using this tool.
Blogs on B7-2/CD86.
CD86 - I work in tandem with CD80
CD86 belongs to the immunoglobulin superfamily of proteins that drive innate and adaptive immune responses. It is an 80kD co-stimulatory molecule for the priming and activation of naive and memory T-cells, respectively. CD86 is expressed on activated... Read full blog post.